Updated:
Jeisys Medical
Jeisys Medical is a asset manager based in Seoul; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
General information
Firm type
Asset Manager
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Additional offices
Burlington, MA, United States
Principals
DH Kang
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Jeisys Medical?
Jeisys is an operating medical device manufacturer, not an investment firm. Strategic and financial decisions are guided by founder DH Kang alongside majority investor Archimed, an $8B healthcare private equity firm that acquired its stake in 2023.
How is Jeisys Medical related to Archimed?
Archimed, a global private equity firm dedicated to healthcare, acquired a majority stake in Jeisys Medical in September 2023 (per the Jeisys website, 2025). The investment is designed to finance Jeisys's direct entry into the U.S. aesthetics market.
Which sectors does Jeisys Medical explicitly avoid?
Jeisys focuses exclusively on energy-based aesthetic devices, specifically RF microneedling, dual-mode RF, and fractional resurfacing platforms. The firm does not operate in surgical aesthetics, injectables, or non-device skincare products.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: